<DOC>
	<DOCNO>NCT00161993</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics , efficacy safety Immune Globulin Intravenous ( Human ) , 10 % TVR ( Triple Virally Reduced ) Solution subject primary immunodeficiency ( PID ) manifest hypo- agammaglobulinemia . Subjects treat every 21 day receive total 12 infusion : first 3 infusion subject receive GAMMAGARD S/D ensure steady-state acquire data licensed product ; remain 9 infusion subject receive IGIV , 10 % TVR Solution .</brief_summary>
	<brief_title>Safety , Pharmacokinetic Efficacy Study 10 % Triple Virally Reduced Intravenous Immune Globulin Solution Patients With Primary Immunodeficiency ( Hypo- Agammaglobulinemia )</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Agammaglobulinemia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Subjects eligible study entry : least 18 year old form primary immunodeficiency ( PID ) describe Rosen et al , 1999 16 manifest agammaglobulinemia ( Xlinked ) hypogammaglobulinemia ( common variable immunodeficiency ) , require immunoglobulin replacement therapy regular treatment least three month either intravenous immunoglobulin preparation immunoglobulin preparation intramuscular use give subcutaneously serum IgG level great equal 5 g/L determine local laboratory screen female childbearing potential , agree employ adequate birth control measure study give write informed consent Subjects eligible study entry : severe adverse reaction treatment immunoglobulin preparation last three treatment inclusion study suffer document selective IgA deficiency antibody IgA acute infection require intravenous antibiotic treatment ( Last treatment day seven day study entry . ) know infected HIV , HCV , HBV high risk contract bloodborne viral infection parenteral drug abuse life style suffer congestive heart failure receive ondemand treatment furosemide show renal dysfunction define serum creatinine great equal 1.5 mg/dL baseline visit receive another investigational drug three week precede study entry case female , pregnant nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Gammaglobulin</keyword>
</DOC>